How much is Zag Bio worth in 2026?

Zag Bio has a current valuation of N/A based on their Early Stage VC round and secondary market data.

How much funding has Zag Bio raised?

Zag Bio has raised $102.0M in total funding across 2 funding rounds.

Zag Bio

Drug DeliveryWebsite

Zag Bio valuation and funding history | Last updated: October 25, 2025 | 2 funding rounds

Current Valuation

N/A

As of October 25, 2025

Total Funding Raised

$102.0M

Across 2 rounds

Last Round

Early Stage VC

$80.0M

Last Funding

Oct 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
N/A	Unknown	Undisclosed	N/A	-
October 25, 2025	Early Stage VC (Series A)	$80.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Zag Bio is currently valued at N/A as of October 25, 2025. The company has raised a total of $102.0M in funding across 2 funding rounds.

Track Zag Bio Valuation Updates

Get notified when Zag Bio raises new funding or valuation changes

Explore More Data

Detailed analysis for Zag Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Zag Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Zag Bio Worth in 2026?

Zag Bio is a leading private company in the Drug Delivery sector. Track Zag Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Zag Bio Valuation is Determined

Private company valuations like Zag Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.